STERIS Stock (NYSE:STE)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$230.46

52W Range

$200.98 - $252.79

50D Avg

$237.76

200D Avg

$224.38

Market Cap

$22.28B

Avg Vol (3M)

$673.03K

Beta

0.92

Div Yield

$2.28 (1.01%)

STE Company Profile


STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

IE

Employees

18,000

IPO Date

Jun 01, 1992

Website

STE Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceMar 25Mar 24Mar 22
Service$2.59B$2.37B$2.03B
Product$2.87B$2.76B$2.56B

Fiscal year ends in Mar 25 | Currency in USD

STE Financial Summary


Mar 25Mar 24Mar 23
Revenue$5.46B$5.14B$4.54B
Operating Income$866.64M$836.12M$268.19M
Net Income$614.64M$378.24M$107.03M
EBITDA$866.64M$1.41B$1.34B
Basic EPS$6.20$3.83$1.07
Diluted EPS$6.16$3.81$1.07

Fiscal year ends in Mar 25 | Currency in USD

Latest Earnings Call Transcripts


Q4 25May 15, 25 | 9:00 AM
Q3 25Feb 06, 25 | 9:00 AM
Q2 25Nov 07, 24 | 9:00 AM

Peer Comparison


TickerCompany
BIOBio-Rad Laboratories, Inc.
CNMDCONMED Corporation
RMDResMed Inc.
MTDMettler-Toledo International Inc.
COOThe Cooper Companies, Inc.
ZBHZimmer Biomet Holdings, Inc.
TFXTeleflex Incorporated
WSTWest Pharmaceutical Services, Inc.
BRKRBruker Corporation
GKOSGlaukos Corporation